Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Short Interest Update

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) saw a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 121,500 shares, a growth of 40.0% from the November 15th total of 86,800 shares. Based on an average daily volume of 81,500 shares, the short-interest ratio is presently 1.5 days.

Analyst Upgrades and Downgrades

EKSO has been the topic of several recent analyst reports. Lake Street Capital cut their target price on Ekso Bionics from $2.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th. StockNews.com assumed coverage on shares of Ekso Bionics in a report on Friday. They issued a “hold” rating for the company. Finally, HC Wainwright lowered their target price on shares of Ekso Bionics from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday, October 29th.

Ekso Bionics Trading Up 0.2 %

Shares of EKSO traded up $0.00 during mid-day trading on Friday, reaching $0.57. The company’s stock had a trading volume of 147,815 shares, compared to its average volume of 115,288. Ekso Bionics has a 1 year low of $0.50 and a 1 year high of $3.13. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.81 and a quick ratio of 2.14. The business has a fifty day moving average of $0.85 and a 200 day moving average of $1.03.

Ekso Bionics (NASDAQ:EKSO) last posted its quarterly earnings results on Monday, October 28th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.08) by ($0.02). The company had revenue of $4.13 million for the quarter, compared to analyst estimates of $6.00 million. Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. During the same quarter in the prior year, the business posted ($0.24) earnings per share. Sell-side analysts predict that Ekso Bionics will post -0.48 EPS for the current fiscal year.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.